A股異動 | 招商蛇口(001979.SZ)反彈逾4% 9月簽約銷售金額同比升27%
格隆匯10月12日丨招商蛇口(001979.SZ)近期股價持續低迷下跌,今日盤中一度反彈逾6%,日前曾創下近2兩年新低價。現報15.86元,漲4.48%,暫成交3.15億元,最新總市值1256.6億元。招商蛇口10月9日公佈,2020年9月,公司實現簽約銷售面積109.44萬平方米,同比增加5.67%;實現簽約銷售金額298.01億元,同比增加27.05%。2020年1-9月,公司累計實現簽約銷售金額1,901.76億元,同比增加17.36%。另外,公司或受益《深圳建設中國特色社會主義先行示範區綜合改革試點實施方案(2020-2025年)》。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.